chartexchange

RCKT
Rocket Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:55 PM EST
2.12USD+0.237%(+0.01)2,491,774
Pre-marketNov 18, 2026 9:27:30 AM EST
2.14USD+1.422%(+0.03)
After-hoursNov 18, 2026 4:12:30 PM EST
2.11USD-0.236%(-0.00)
Loading…
Loading…
236.16M
Healthcare
Biotechnology
CEO
Gaurav Shah
HQ
Cranbury, NJ, USA
Previous Close
$2.11
Beta
1.77
52-Week High
$5.45 2026-03-10
52-Week Low
$2.03 2026-11-17
SMA 50
$2.62
SMA 200
$3.37
Avg. Vol 10D
1.65M
Avg. Vol 30D
1.93M
Avg. Vol 90D
1.74M
Relative Vol
1.29
111.66M
89.56M
16,242,429
1.0100%
1,900,000
333
Jan 5, 2018 · 1-for-4 (reverse)
RCKT Profile

rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of manufacturing and cell processing expertise, while building an internal team to drive the research, development, clinical and regulatory programs. ultimately we aim to launch and globally commercialize innovative gene therapies in disease areas with high unmet need. for more information, please visit www.rocketpharma.com.

RCKT Performance
PeriodPriceDateChangeBeta
1W2.392026-11-12-11.51%2.632
1M2.242026-10-19-5.58%1.844
3M3.652026-08-19-42.05%1.556
6M2.922026-05-19-27.57%1.355
1Y2.882025-11-19-26.56%1.770
2Y13.162024-11-19-83.93%—
5Y27.872021-11-19-92.41%1.682
RCKT Stock Summary

Rocket Pharmaceuticals, Inc. Common Stock (NASDAQ:RCKT) stock price today is $2.12, and today's volume is 2,491,774. RCKT is up 0.237% today. The 30 day average volume is 1.93M. RCKT market cap is $236.16M with 111.66M shares outstanding.